Results 301 to 310 of about 168,641 (363)
Hemodynamic and renal effects of atrial natriurectic peptide in normal men [PDF]
, 1988 Ball, P., Heim, J. M., Lawrenz, R., Müller-Esch, G., Potratz, J., Scriba, Peter Christian +5 morecore Degradation and clearance of atrial natriuretic factors [PDF]
, 1990 Adnot, Almeida, Anand-Srivastava, Anand-Srivastava, Anderson, Ando, Arendt, Arendt, Ballermann, Ballermann, Bates, Bertrand, Bianchi, Bianchi, Cachofeiro, Cantin, Cantin, Chartier, Chinkers, Cody, Crozier, De Bold, De Lean, Drexler, Espiner, Fethiere, Fulcher, Gerbes, Gerbes, Gerbes, Gines, Gros, Gutkowska, Hasegawa, Henriksen, Hinko, Hollister, Inagami, Kenny, Koehn, Koepke, Kollenda, Koseki, Krieter, Kurosawa, Lafferty, Laffi, Lang, Lang, Laragh, Leitman, Lieorens, Luft, Maack, Mantyh, Marumo, Masuda, Matsas, Matsas, Matsas, Misono, Murthy, Nakao, Needleman, Northridge, Olins, Olins, Olins, Pandey, Porter, Predel, Raine, Richards, Riegger, Saito, Scarborough, Schafferhans, Schiebinger, Schutten, Schwartz, Seymour, Shima, Sonnenberg, Stephenson, Stewart, Sudhir, Sugiyama, Sybertz, Sybertz, Takayanagi, Tamburini, Tang, Thibault, Trapani, Trapani, Trippodo, Vierhapper, Vollmar, Vollmar, Vollmar, Webb, Woods, Yukimura +102 morecore +1 more sourceAssociation of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study
European Journal of Heart Failure, EarlyView.Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim
Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar +9 morewiley +1 more sourceQuality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
European Journal of Heart Failure, EarlyView.For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...Maurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, Pier Giuseppe Agostoni, Javed Butler, Andrew J.S. Coats, Alan Cohen‐Solal, Wolfram Doehner, Gerasimos Filippatos, Ewa Jankowska, Carolyn S.P. Lam, Ekaterini Lambrinou, Lars H. Lund, Giuseppe Rosano, Marco Metra, Stefania Paolillo, Pasquale Perrone Filardi, Amina Rakisheva, Gianluigi Savarese, Petar Seferovic, Carlo Gabriele Tocchetti, Massimo Piepoli +21 morewiley +1 more sourceThe Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis
European Journal of Heart Failure, EarlyView.Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo +11 morewiley +1 more sourceProteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts
European Journal of Heart Failure, EarlyView.Markers of progression to heart failure (HF). Gal‐4, galectin‐4; GDF‐15, growth differentiation factor 15; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; ST2, suppression of tumorigenicity‐2. ABSTRACT Aims
Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart ...Anna Dieden, Nicolas Girerd, Filip Ottosson, John Molvin, Manan Pareek, Olle Melander, Erasmus Bachus, Lennart Råstam, Ulf Lindblad, Bledar Daka, Margrét Leósdóttir, Peter M. Nilsson, Michael H. Olsen, Andrew L. Clark, John G.F. Cleland, Christian Delles, Arantxa González, Zohra Lamiral, Kevin Duarte, Patrick Rossignol, Faiez Zannad, Petri Gudmundsson, Amra Jujić, Martin Magnusson +23 morewiley +1 more sourceRelevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right‐sided heart failure
European Journal of Heart Failure, EarlyView.Right ventricular reverse remodelling after transcatheter tricuspid valve intervention (TTVI). Optimal tricuspid regurgitation (TR) reduction is critical for right ventricular reverse remodelling. CMR, cardiac magnetic resonance; echo, echocardiography; RV EDV, right ventricular end‐diastolic volume. Abstract Aims
Right ventricular reverse remodelling (Ludwig T. Weckbach, Lukas Stolz, Philipp M. Doldi, Hannah Glaser, Cecilia Ennin, Michael Kothieringer, Thomas J. Stocker, Michael Näbauer, Mohammad Kassar, Sara Bombace, Karl‐Patrik Kresoja, Philipp Lurz, Fabien Praz, Holger Thiele, Volker Rudolph, Steffen Massberg, Jörg Hausleiter +16 morewiley +1 more source
